PT - JOURNAL ARTICLE AU - Leslie A Lenert AU - Vivienne Zhu AU - Lindsey Jennings AU - Jenna L McCauley AU - Jihad S Obeid AU - Ralph Ward AU - Saeed Hassanpour AU - Lisa A Marsch AU - Michael Hogarth AU - Perry Shipman AU - Daniel R Harris AU - Jeffery C Talbert TI - Enhancing Research Data Infrastructure to Address the Opioid Epidemic: The Opioid Overdose Network (02-Net) AID - 10.1101/2021.07.15.21260134 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.15.21260134 4099 - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260134.short 4100 - http://medrxiv.org/content/early/2021/07/19/2021.07.15.21260134.full AB - Objective Opioid Overdose Network is an effort to generalize and adapt an existing research data network, the Accrual to Clinical Trials (ACT) Network, to support design of trials for survivors of opioid overdoses presenting to emergency departments (ED). Four institutions (Medical University of South Carolina (MUSC), Dartmouth Medical School (DMS), University of Kentucky (UK), and University of California San Diego (UCSD)) worked to adapt ACT network. This paper reports their progress.Materials and Methods The approach taken to enhancing ACT network focused on four activities: cloning and extending the ACT infrastructure, developing an e-phenotype and corresponding registry, developing portable natural language processing (NLP) tools to enhance data capture, and developing automated documentation templates to enhance extended data capture.Results All four institutions were able to replicate their i2b2 and Shared Health Research Information Network (SHRINE) infrastructure. A five category e-phenotype model based on ICD-10 coding was developed from prior published work. Ongoing work is refining this via machine learning and artificial intelligence methods. Portable NLP tools, focused at the sentence level, were also developed to identify uncoded opioid overdose related concepts in provider notes.Optimal performance was seen in NLP tools that combined rule-based with deep learning methods (F score, 0.94). A template for ED overdose documentation was developed to improve primary data capture. Interactive prompts to physicians inside ED progress notes were effective in promoting use of the template. The template had good system usability and net promoter scores (0.72 and 0.75, respectively, n=13). Work to design ED trials based on the network’s data is underway.Discussion and Conclusions Overall, initial results suggest that tailoring of existing multipurpose research networks to specific tasks is feasible; however, substantial efforts are required for coordination of the subnetwork and development of new tools for extension of available data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis publication [or project] was supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Grant Numbers U01TR002628, UL1TR001450, UL1TR001998, UL1TR001442, and UL1TR001086. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project has been approved by the MUSC Institutional Review Board (IRB) on 5/14/2019 as an exempt IRB protocol under protocol number Pro00088536. Additional certifications were obtained on 04/02/21 for a software user satisfaction survey classifying this specific work as a quality improvement activity.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData in this manuscript are available on written request to the principal investigator.